Mereo BioPharma Group Plc (MREO)
0.3798
+0.01
(+3.52%)
USD |
NASDAQ |
Oct 02, 16:00
0.3726
-0.01
(-1.90%)
After-Hours: 20:00
Mereo BioPharma Group Net Income (Quarterly) : -7.018M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.018M |
| March 31, 2026 | -6.708M |
| December 31, 2025 | -7.340M |
| September 30, 2025 | -6.980M |
| June 30, 2025 | -14.80M |
| Date | Value |
|---|---|
| March 31, 2025 | -12.94M |
| December 31, 2024 | -6.981M |
| September 30, 2024 | -15.15M |
| June 30, 2024 | -12.27M |
| March 31, 2024 | -8.946M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -4.134M |
| BioNTech SE | -954.35M |
| Silence Therapeutics Plc | -12.27M |
| Autolus Therapeutics Plc | -39.18M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.018M |
| EPS Diluted (Quarterly) | -0.0437 |
| Enterprise Value | 31.54M |
| Earnings Yield | -46.13% |
| Normalized Earnings Yield | -46.74 |